TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 27455318

Group type: EXPERIMENTAL
Intervention: Glucerna (GL)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Ultra Glucose Control (UGC)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Oatmeal (OM)
Number of subjects: 22
Study: 25154994

Group type: EXPERIMENTAL
Intervention: Elastic intramedullary nail
Number of subjects: 84

Group type: COMPARATOR
Intervention: Conventional plating
Number of subjects: 84
Study: 22209292

Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV-6/11/16/18 vaccine
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Monovalent HPV-16 vaccine
Number of subjects: 52
Study: 21119659

Group type: EXPERIMENTAL
Intervention: Information about trial logic, voluntary nature, and rights to withdraw provided to patients.
Number of subjects: 1066

Group type: EXPERIMENTAL
Intervention: Previous trial experience
Number of subjects: 1066

Group type: EXPERIMENTAL
Intervention: Male gender
Number of subjects: 1066

Group type: EXPERIMENTAL
Intervention: Age <70 years
Number of subjects: 1066
Study: 17201904

Group type: EXPERIMENTAL
Intervention: Nicotine transdermal patches with behavioural support
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Placebo transdermal patches with behavioural support
Number of subjects: 1050
Study: 16298890

Group type: EXPERIMENTAL
Intervention: Native language presentation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Secondary language presentation
Number of subjects: 0
Study: 12887807

Group type: EXPERIMENTAL
Intervention: Glass ionomer cement
Number of subjects: 22

Group type: COMPARATOR
Intervention: Composite resin
Number of subjects: 22
Study: 10612536

Group type: EXPERIMENTAL
Intervention: Cytokine treatment (placebo-controlled)
Number of subjects: 363

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 363
Study: 7741639

Group type: EXPERIMENTAL
Intervention: Sealing with autologous adipose tissue
Number of subjects: 36
Study: 2115379

Group type: EXPERIMENTAL
Intervention: Buserelin, 1200 micrograms/day intranasally for 3 months
Number of subjects: 24

Group type: COMPARATOR
Intervention: Immediate myomectomy
Number of subjects: 24
Study: 94155

Group type: EXPERIMENTAL
Intervention: Electrophoretic mobility test (EM test)
Number of subjects: 130
Study: 30398862

Group type: EXPERIMENTAL
Intervention: In vitro assessment of melanin binding properties of small molecules
Number of subjects: 3400

Group type: EXPERIMENTAL
Intervention: In silico model predicting melanin binding
Number of subjects: 3400

Group type: EXPERIMENTAL
Intervention: Correlations between melanin binding and molecular properties
Number of subjects: 3400
Study: 27317305

Group type: EXPERIMENTAL
Intervention: Single dose of peramivir 150 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single dose of peramivir 300 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Single dose of peramivir 600 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Multiple dose of peramivir 600 mg
Number of subjects: 12
Study: 24285801

Group type: EXPERIMENTAL
Intervention: Rehabilitation programme (supervised training and home exercises)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Educational-behavioural programme
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 69
Study: 22424799

Group type: EXPERIMENTAL
Intervention: Methadone (METH)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP)
Number of subjects: 82

Group type: COMPARATOR
Intervention: Control (drug-free)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Methadone (METH) and Buprenorphine (BUP)
Number of subjects: 82
Study: 20384415

Group type: EXPERIMENTAL
Intervention: Sequential name‐face matching task with famous faces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential name‐face matching task with nonfamous faces
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sequential face-name matching task with names
Number of subjects: 0
Study: 18025064

Group type: EXPERIMENTAL
Intervention: Net Present Value risk communication intervention
Number of subjects: 100

Group type: COMPARATOR
Intervention: Future Value risk communication intervention (Control)
Number of subjects: 100
Study: 16112972

Group type: EXPERIMENTAL
Intervention: Ramipril
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vitamin E
Number of subjects: 0
Study: 12005458

Group type: EXPERIMENTAL
Intervention: Early enteral feeding (started on day 1)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Late enteral feeding (started on day 5, with 20% of estimated daily requirements during the first 4 days)
Number of subjects: 150
Study: 10424513

Group type: EXPERIMENTAL
Intervention: IV levofloxacin, 500 mg qd for 7 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: IV alatrofloxacin, 200 mg qd for 7 days
Number of subjects: 12
Study: 7584749

Group type: EXPERIMENTAL
Intervention: Chest compressions with audible tone guidance
Number of subjects: 12

Group type: COMPARATOR
Intervention: Chest compressions without audible tone guidance
Number of subjects: 12
Study: 2207399

Group type: EXPERIMENTAL
Intervention: Chloroquine 25 mg/kg over three days
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Pyrimethamine 75 mg and sulfadoxine 1500 mg as a single dose
Number of subjects: 263

Group type: EXPERIMENTAL
Intervention: Chlorproguanil 1.2 mg/kg and dapsone 2.4 mg/kg as a single dose
Number of subjects: 263
Study: 6993445

Group type: EXPERIMENTAL
Intervention: Diethylpropion hydrochloride
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 30633917

Group type: EXPERIMENTAL
Intervention: Regular vaginal assessments (4-hourly prior to each oral misoprostol dose)
Number of subjects: 204

Group type: COMPARATOR
Intervention: Restricted vaginal assessments (only if indicated)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Regular vaginal assessments
Number of subjects: 204

Group type: COMPARATOR
Intervention: Restricted vaginal assessments
Number of subjects: 204
Study: 28432578

Group type: EXPERIMENTAL
Intervention: Rise intervention (6-month culturally congruent adherence counseling)
Number of subjects: 215

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 215
Study: 24259197

Group type: EXPERIMENTAL
Intervention: Brief alcohol intervention
Number of subjects: 664
Study: 23504383

Group type: EXPERIMENTAL
Intervention: adalimumab 40 mg every other week for 24 weeks
Number of subjects: 136

Group type: COMPARATOR
Intervention: placebo every other week for 24 weeks
Number of subjects: 136
Study: 21642927

Group type: EXPERIMENTAL
Intervention: Structured Education Pulmonary Rehabilitation Programme (SEPRP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nurses working in primary care
Number of subjects: 0
Study: 19546510

Group type: EXPERIMENTAL
Intervention: Excimer laser treatment
Number of subjects: 325
Study: 16990120

Group type: EXPERIMENTAL
Intervention: 3-hour online training program for workplace violence (WPV)
Number of subjects: 43
Study: 15247354

Group type: COMPARATOR
Intervention: Doxorubicin alone (30 mg/m² every three weeks for 10 doses)
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Dexrazoxane (300 mg/m²) followed by doxorubicin
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: Both groups (doxorubicin alone and dexrazoxane + doxorubicin)
Number of subjects: 206
Study: 11770708

Group type: EXPERIMENTAL
Intervention: Low-dose pravastatin (5 mg/day)
Number of subjects: 665

Group type: COMPARATOR
Intervention: Standard-dose pravastatin (10-20 mg/day)
Number of subjects: 665
Study: 9037443

Group type: EXPERIMENTAL
Intervention: Test DPI (Easyhaler)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Reference DPI
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Both DPIs
Number of subjects: 25
Study: 11830951

Group type: EXPERIMENTAL
Intervention: Low level laser therapy applied during and following third molar removal
Number of subjects: 0

Group type: COMPARATOR
Intervention: No active additional laser treatment (placebo)
Number of subjects: 0
Study: 2737688

Group type: EXPERIMENTAL
Intervention: Propranolol (PROP)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine (NIF)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide (HCT)
Number of subjects: 0
Study: 30902043

Group type: EXPERIMENTAL
Intervention: Myocardial flow reserve (MFR) measured with 82Rb-PET/CT
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Coronary vascular resistance during stress
Number of subjects: 151
Study: 25913062

Group type: EXPERIMENTAL
Intervention: 10Hz transcranial alternating current stimulation (10Hz-tACS) of the frontal cortex
Number of subjects: 20

Group type: COMPARATOR
Intervention: 40Hz transcranial alternating current stimulation (40Hz-tACS) of the frontal cortex
Number of subjects: 20
Study: 23886027

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) 1200 mg/day + risperidone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo + risperidone
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: N-Acetylcysteine (NAC) + risperidone
Number of subjects: 40
Study: 21087377

Group type: EXPERIMENTAL
Intervention: Didanosine (ddI) combined with lamivudine and efavirenz or nevirapine
Number of subjects: 151

Group type: COMPARATOR
Intervention: Zidovudine (ZDV) combined with lamivudine and efavirenz or nevirapine
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Didanosine (ddI)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Zidovudine (ZDV)
Number of subjects: 151
Study: 19139252

Group type: EXPERIMENTAL
Intervention: Experience Corps (EC)
Number of subjects: 149

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 149
Study: 16800986

Group type: EXPERIMENTAL
Intervention: Kanlijian (KLJ) combined with conventional therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 60
Study: 12862327

Group type: EXPERIMENTAL
Intervention: Valsalva maneuver at 40 mmHg expiratory pressure for 15 seconds
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Responders (n = 20)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Combined groups
Number of subjects: 33
Study: 10759275

Group type: EXPERIMENTAL
Intervention: National guidelines adapted to local protocols
Number of subjects: 946
Study: 8798135

Group type: EXPERIMENTAL
Intervention: Carotid endarterectomy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Carotid angioplasty with stent technology
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minimally invasive carotid interventions
Number of subjects: 0
Study: 1875441

Group type: EXPERIMENTAL
Intervention: Ascorbic acid and alpha‐tocopherol
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Alpha‐tocopherol
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 7051762

Group type: EXPERIMENTAL
Intervention: Alprenolol
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Alprenolol and Metoprolol
Number of subjects: 6
Study: 31928920

Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) granules based on syndrome differentiation (Bao‐fei Hua‐xian granule, Jin‐shui Huan‐xian granule, Yang‐qing Kang‐xian granule)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo TCM granules
Number of subjects: 80
Study: 30604204

Group type: EXPERIMENTAL
Intervention: Supervised walking program (3 times a week for 16 weeks)
Number of subjects: 45
Study: 29051138

Group type: EXPERIMENTAL
Intervention: Physiotherapist-guided Ambulant Activity Feedback (AAF) therapy (n=62)
Number of subjects: 167

Group type: EXPERIMENTAL
Intervention: Psychologist-guided Web-based mindfulness-based cognitive therapy (eMBCT; n=55)
Number of subjects: 167

Group type: COMPARATOR
Intervention: Unguided active control condition receiving psycho-educational emails (n=50)
Number of subjects: 167
Study: 27468664

Group type: EXPERIMENTAL
Intervention: Smoking relapse-prevention intervention (SRP) group: standard of care plus 8 relapse-prevention booklets mailed over a 3-month period and a targeted educational DVD developed specifically for cancer patients.
Number of subjects: 414

Group type: COMPARATOR
Intervention: Usual Care (UC) group: received the institution's standard of care.
Number of subjects: 414
Study: 24327135

Group type: EXPERIMENTAL
Intervention: Family instrumental support
Number of subjects: 1422

Group type: EXPERIMENTAL
Intervention: Baseline family instrumental support
Number of subjects: 1422

Group type: COMPARATOR
Intervention: Emotional support from family or peers
Number of subjects: 1422
Study: 22728693

Group type: EXPERIMENTAL
Intervention: Single MRI slice 5-10 cm above L(4)-L(5)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Single MRI slice L(4)-L(5)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Single MRI slice
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: Multislice imaging
Number of subjects: 123
Study: 19846026

Group type: EXPERIMENTAL
Intervention: Entecavir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lamivudine
Number of subjects: 0
Study: 17561998

Group type: COMPARATOR
Intervention: Vehicle instillation (100 ml of 10% ethanol in saline)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: RTX instillation (100 ml of 50 nM RTX in 10% ethanol in saline)
Number of subjects: 23
Study: 15447895

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation (3.0 g/d; 50:50 blend of cis-9,trans-11 CLA and trans-10,cis-12 CLA)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Conjugated linoleic acid (CLA) supplementation
Number of subjects: 32
Study: 11451718

Group type: EXPERIMENTAL
Intervention: High-protein diet (wheat gluten)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control diet
Number of subjects: 20
Study: 9742535

Group type: EXPERIMENTAL
Intervention: Penile block plus diclofenac suppository (Group 2)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Diclofenac suppository alone (Group 3)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Penile block (Group 1)
Number of subjects: 61
Study: 7724748

Group type: EXPERIMENTAL
Intervention: CT imaging
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: MR imaging
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: Gradient‐echo and T1‐weighted spin‐echo sequences
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: T1‐weighted spin‐echo sequences
Number of subjects: 189

Group type: EXPERIMENTAL
Intervention: T2‐weighted spin‐echo sequences
Number of subjects: 189
Study: 2643284

Group type: EXPERIMENTAL
Intervention: Nicardipine (n = 57)
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo (n = 32)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Nicardipine
Number of subjects: 89

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 89
Study: 1089363

Group type: EXPERIMENTAL
Intervention: L-tryptophan alone
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: L-tryptophan combined with L-dopa
Number of subjects: 12

Group type: COMPARATOR
Intervention: L-dopa combined with L-tryptophan
Number of subjects: 12
Study: 31952931

Group type: EXPERIMENTAL
Intervention: NC+AC group (phosphoric acid, sodium hypochlorite, and sulfinic acid sodium salt)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: NC group (phosphoric acid and sodium hypochlorite)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Control group (no pretreatment)
Number of subjects: 36
Study: 30898897

Group type: EXPERIMENTAL
Intervention: Brock model (original)
Number of subjects: 7879

Group type: EXPERIMENTAL
Intervention: Brock model (updated after recalibration)
Number of subjects: 7879

Group type: EXPERIMENTAL
Intervention: New covariates (including pack-year history)
Number of subjects: 7879
Study: 28488449

Group type: EXPERIMENTAL
Intervention: Individualized medication training (20 min)
Number of subjects: 104

Group type: COMPARATOR
Intervention: Standard treatment without training
Number of subjects: 104
Study: 26050238

Group type: EXPERIMENTAL
Intervention: Yale Pharyngeal Residue Severity Rating Scale
Number of subjects: 261
Study: 23993258

Group type: EXPERIMENTAL
Intervention: Carotid revascularization (carotid endarterectomy or stenting)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: No-to-mild WML
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Moderate WML
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Severe WML
Number of subjects: 89
Study: 21269454

Group type: EXPERIMENTAL
Intervention: Screening for silent ischemia using a bicycle exercise test or Dipyridamole Single Photon Emission Computed Tomography (N = 316)
Number of subjects: 631

Group type: COMPARATOR
Intervention: Follow-up without screening (usual care) (N = 315)
Number of subjects: 631

Group type: EXPERIMENTAL
Intervention: Meta-analysis of DYNAMIT and DIAD results
Number of subjects: 631
Study: 19692788

Group type: EXPERIMENTAL
Intervention: Virtual reality therapy (30 mins per session, in addition to conventional therapy)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Conventional physical therapy (40 mins a day, 4 days a week for 4 weeks)
Number of subjects: 24
Study: 16369817

Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Resistance training
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Resistance training (for low responders to endurance training)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (n=18)
Number of subjects: 91
Study: 15015820

Group type: EXPERIMENTAL
Intervention: Euphyllin Retard 350 mg under fasting condition
Number of subjects: 10

Group type: COMPARATOR
Intervention: Euphyllin Retard 350 mg with breakfast
Number of subjects: 10
Study: 11168211

Group type: EXPERIMENTAL
Intervention: Astra-Tech (A) system - self-tapping TiO2-blasted screw-shaped implants made of commercially pure titanium
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brånemark (B) system - self-tapping Mark II implants with machined surface irregularities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Astra-Tech (A) system
Number of subjects: 0

Group type: COMPARATOR
Intervention: Brånemark (B) system
Number of subjects: 0
Study: 9504133

Group type: EXPERIMENTAL
Intervention: Nasal breathing
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oral breathing
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Nasal breathing at 60 W
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oral breathing at 60 W
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both breathing methods at unloaded exercise
Number of subjects: 8
Study: 8439713

Group type: EXPERIMENTAL
Intervention: Xylocaine/proliferant injections
Number of subjects: 79

Group type: COMPARATOR
Intervention: Xylocaine/saline solution injections
Number of subjects: 79

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 79
Study: 3516606

Group type: EXPERIMENTAL
Intervention: Closed-loop intraperitoneal insulin infusion
Number of subjects: 8

Group type: COMPARATOR
Intervention: Intravenous insulin infusion
Number of subjects: 8
Study: 31786338

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Resistance Band (RB) exercise
Number of subjects: 69

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Depression symptoms
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: CRP levels
Number of subjects: 69
Study: 29450468

Group type: EXPERIMENTAL
Intervention: mFOLFOXIRI plus cetuximab
Number of subjects: 143

Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 143
Study: 27779946

Group type: EXPERIMENTAL
Intervention: Active processing condition
Number of subjects: 50

Group type: COMPARATOR
Intervention: Passive processing condition
Number of subjects: 50
Study: 24368727

Group type: EXPERIMENTAL
Intervention: NAP/ESO
Number of subjects: 2317
Study: 22219470

Group type: EXPERIMENTAL
Intervention: Totally thoracoscopic closure on perfused beating hearts
Number of subjects: 24

Group type: COMPARATOR
Intervention: Totally thoracoscopic closure on cardioplegic arrested hearts
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 24
Study: 20305865

Group type: EXPERIMENTAL
Intervention: Systemic metronidazole plus amoxicillin (AP+AB)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Scaling and root planing with placebo tablets (CP)
Number of subjects: 97
Study: 18534556

Group type: EXPERIMENTAL
Intervention: N-acetyl cysteine (NAC) 1 g twice daily adjunctive to usual medication
Number of subjects: 75
Study: 15915863

Group type: EXPERIMENTAL
Intervention: HPL method of instruction
Number of subjects: 2

Group type: COMPARATOR
Intervention: Standard lecture sequence
Number of subjects: 2
Study: 12074271

Group type: EXPERIMENTAL
Intervention: Aprindine (40 mg/day)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Digoxin (0.25 mg/day)
Number of subjects: 141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Aprindine vs Placebo
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Digoxin vs Placebo
Number of subjects: 141
Study: 9951791

Group type: EXPERIMENTAL
Intervention: Isometric and isotonic exercise until exhaustion
Number of subjects: 110
Study: 7776678

Group type: EXPERIMENTAL
Intervention: Leukocyte filter
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control
Number of subjects: 32
Study: 2334012

Group type: EXPERIMENTAL
Intervention: Chlorhexidine surgical scrub left on hands
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard rinse of one hand
Number of subjects: 50
Study: 323659

Group type: EXPERIMENTAL
Intervention: Dalkon Shield
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lippes Loop
Number of subjects: 0

Group type: COMPARATOR
Intervention: Inhiband
Number of subjects: 0
Study: 30898608

Group type: EXPERIMENTAL
Intervention: Ticagrelor (180-mg loading dose, 90 mg twice daily thereafter)
Number of subjects: 3799

Group type: COMPARATOR
Intervention: Clopidogrel (300- to 600-mg loading dose, 75 mg daily thereafter)
Number of subjects: 3799
Study: 28551840

Group type: EXPERIMENTAL
Intervention: Endometrial scratching
Number of subjects: 144

Group type: COMPARATOR
Intervention: Control (no endometrial scratching)
Number of subjects: 144
Study: 25556301

Group type: EXPERIMENTAL
Intervention: Partial-body cryotherapy (PBC) at -110 °C for 3 minutes
Number of subjects: 26

Group type: COMPARATOR
Intervention: Control group exposed to 21 °C for 3 minutes
Number of subjects: 26